Proton therapy developer Ion Beam Applications (IBA) said that its proton therapy-specific conebeam CT (CBCT) technology is in clinical use for the first time worldwide.
Penn Medicine's Roberts Proton Therapy Center in Philadelphia treated the first patient, according to IBA. The CBCT technology offers 3D imaging capability and is a component of IBA's image-guided proton therapy platform.